CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Vita 34 International Ag Company Snapshot
Vita 34 International Ag operates in the Health and allied services sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vita 34 International Ag with three other health care providers in Europe: Celyad SA of Belgium (2016 sales of 8.52 million Euro [US$10.03 million] of which 99% was Immuno-Oncology), Esperite NV of the Netherlands (26.25 million Euro [US$30.89 million] ), and Institut Stvolovykh Kletok Cheloveka PAO which is based in Russia (390.36 million Russian Rubles [US$6.81 million] ).

Sales Analysis. Vita 34 International Ag reported sales of 16.29 million Euro (US$19.16 million) for the year ending December of 2016. This represents an increase of 15.0% versus 2015, when the company's sales were 14.17 million Euro. This was the third consecutive year of growth at Vita 34 International Ag. The sales level in 2016 was fairly close to the level five years ago: in 2011, Vita 34 International Ag had sales of 16.00 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Vita 34 International Ag
  Stock Performance Chart for Vita 34 International Ag
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 12.30
(Figures in Euro)
1 Week -4.4%   13 Weeks 20.3%  
4 Weeks 70.3%   52 Weeks 148.5%  
 
Vita 34 International Ag Key Data:
  Ticker: V3V Country: Germany
  Exchanges: FRA Major Industry: Health Care Equipment & Services
    Sub Industry: Health & Allied Services
  2016 Sales 16,290,000
(Year Ending Jan 2017).
Employees: 122
  Currency: Euro Market Cap: 51,664,109
  Fiscal Yr Ends: December Shares Outstanding: 4,200,334
  Share Type: Namensaktie Closely Held Shares: 1,184,549
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.